局部晚期食管癌新辅助放化疗后非肿瘤累及食管晚期FDG摄取增高可预测病理完全缓解和疾病复发
回顾性纳入64例完成新辅助放化疗并成功行肿瘤切除的局部晚期食管癌患者,于再分期PET/CT测定肿瘤及非肿瘤累及食管的SUVmax与SUVmean。非肿瘤累及食管FDG摄取增高与病理完全缓解显著相关(p=0.002),并与总生存改善、局部控制更好、治疗失败率更低及远处转移更少相关。作者认为照射正常组织的FDG摄取具有显著预后价值,可能有助于治疗个体化。
要点
- 非肿瘤累及食管再分期PET的SUVmean增高与病理完全缓解显著相关(p=0.002)。
- 非肿瘤累及食管SUVmax和SUVmean增高与总生存改善、局部控制更好、治疗失败率更低及远处转移更少相关。
- 多因素分析中非肿瘤累及食管SUVmax和SUVmean仍为治疗失败和远处转移的显著预后因素。
核心结论
- 再分期PET所测照射正常组织的FDG摄取在局部晚期食管癌新辅助放化疗患者中具有显著预后价值。
- 该效应可能有助于治疗个体化。
研究设计与样本
- 回顾性评估纳入64例局部晚期食管癌患者,均完成新辅助放化疗并成功行肿瘤切除。
- 所有患者在新辅助放化疗前后接受FDG PET/CT,于再分期PET测定肿瘤及非肿瘤累及食管的SUVmax和SUVmean。
- 采用单因素Cox回归分析总生存、局部控制、远处转移和治疗失败,并在多因素Cox回归中检验临床相关参数的独立性。
主要发现
- 再分期时非肿瘤累及食管SUVmean增高与完全病理缓解显著相关(p=0.002),且与肿瘤FDG反应无高度相关性(rho < 0.3)。
- 单因素分析中,非肿瘤累及食管SUVmax和SUVmean增高与总生存改善相关(p=0.011,p=0.004)。
- 单因素分析中,非肿瘤累及食管SUVmax和SUVmean增高与局部控制更好相关(p=0.051,p=0.044)。
- 单因素分析中,非肿瘤累及食管SUVmax和SUVmean增高与治疗失败率更低相关(两者p < 0.001),并与远处转移相关(p=0.012,p=0.001)。
- 多因素分析中,非肿瘤累及食管SUVmax和SUVmean仍为治疗失败的显著预后因素(p < 0.001,p=0.004)及远处转移的显著预后因素(p=0.040,p=0.011)。
关键数值与推荐
- 非肿瘤累及食管SUVmean增高与完全病理缓解相关(p=0.002)。
- 非肿瘤累及食管SUVmax增高与总生存改善相关(p=0.011),SUVmean增高与总生存改善相关(p=0.004)。
- 非肿瘤累及食管SUVmax增高与局部控制更好相关(p=0.051),SUVmean增高与局部控制更好相关(p=0.044)。
- 非肿瘤累及食管SUVmax和SUVmean增高与治疗失败率更低相关(两者p < 0.001)。
- 非肿瘤累及食管SUVmax增高与远处转移相关(p=0.012),SUVmean增高与远处转移相关(p=0.001)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Early side effects including oesophagitis are potential prognostic factors in patients undergoing radiochemotherapy (RCT) for locally advanced oesophageal cancer (LAEC). We assessed the prognostic value of 18F-fluorodeoxyglucose (FDG) uptake within irradiated non-tumour-affected oesophagus (NTO) during restaging positron emission tomography (PET) as a surrogate for inflammation/oesophagitis. METHODS: This retrospective evaluation included 64 patients with LAEC who had completed neoadjuvant RCT and had successful oncological resection. All patients underwent FDG PET/CT before and after RCT. In the restaging PET scan maximum and mean standardized uptake values (SUVmax, SUVmean) were determined in the tumour and NTO. Univariate Cox regression with respect to overall survival, local control, distant metastases and treatment failure was performed. Independence of clinically relevant parameters was tested in a multivariate Cox regression analysis. RESULTS: Increased FDG uptake, measured in terms of SUVmean in NTO during restaging was significantly associated with complete pathological remission (p = 0.002) and did not show a high correlation with FDG response of the tumour (rho < 0.3). In the univariate analysis, increased SUVmax and SUVmean in NTO was associated with improved overall survival (p = 0.011, p = 0.004), better local control (p = 0.051, p = 0.044), a lower rate of treatment failure (p < 0.001 for both) and development of distant metastases (p = 0.012, p = 0.001). In the multivariate analysis, SUVmax and SUVmean in NTO remained a significant prognostic factor for treatment failure (p < 0.001, p = 0.004) and distant metastases (p = 0.040, p = 0.011). CONCLUSIONS: FDG uptake in irradiated normal tissues measured on restaging PET has significant prognostic value in patients undergoing neoadjuvant RCT for LAEC. This effect may potentially be of use in treatment personalization.
引用
- Zschaeck S, Hofheinz F, Zöphel K, et al. Increased FDG uptake on late-treatment PET in non-tumour-affected oesophagus is prognostic for pathological complete response and disease recurrence in patients undergoing neoadjuvant radiochemotherapy. Eur J Nucl Med Mol Imaging. 2017. PMID: 28600646. doi:10.1007/s00259-017-3742-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。